Estimated Vaccination Coverage*,† among Adolescents Aged 13-17 Years§, by Race/ethnicity¶ for Selected Vaccines -- National Immunization Survey-Teen, United States, 2008
Vaccines  White only,
non-Hispanic
% (95% CI)
Black only,
non-Hispanic
% (95% CI)
Hispanic
% (95% CI)
American Indian or Alaska Native only,
non-Hispanic
% (95% CI)
Asian only,
non-Hispanic
% (95% CI)
> 2 MMR**89.9 (88.8-90.8)89.1 (86.5-91.2)87.5 (84.4-90.0)93.9 (88.3-96.9)87.2 (77.3-93.1)
> 3 HepB††88.1 (87.0-89.1)86.0 (83.3-88.3)89.8 (87.0-92.0)86.6 (77.6-92.4)89.9 (80.0-95.2)
Varicella
History of varicella disease§§63.1 (61.6-64.6)53.5 (49.2-57.7)55.1 (50.5-59.7)66.2 (54.0-76.5)58.2 (48.1-67.6)
Among adolescents without history of disease:
>1 dose vaccine82.8 (81.0-84.5)74.0 (68.4-78.9)84.5 (79.0-88.8)83.5 (68.4-92.2)89.1 (82.0-93.6)
>2 dose vaccine31.6 (29.4-33.9)35.0 (28.1-42.6)38.5 (31.8-45.8)41.8 (22.3-64.2)36.1 (24.0-50.3)
History of disease or received =1 dose varicella vaccination93.7 (93.0-94.3)87.9 (85.1-90.2)93.0 (90.4-95.0)94.4 (88.9-97.3)95.4 (92.4-97.3)
Td or Tdap since age 10 years¶¶
>1 dose Td or Tdap71.6 (70.1-73.0)71.4 (67.6-74.9)74.1 (70.0-77.8)81.4 (72.6-87.8)76.9 (67.2-84.4)
>1 dose Tdap41.7 (40.1-43.3)36.0 (31.9-40.2)41.9 (37.5-46.5)43.5 (31.7-56.1)44.4 (34.4-54.9)
MCV4 1 dose***39.7 (38.2-41.2)43.1 (39.0-47.3)46.8 (42.2-51.4)47.3 (35.4-59.5)50.5 (40.3-60.8)
HPV4†††
>1 dose 35.0 (32.9-37.2)35.7 (29.6-42.4)44.4 (38.0-50.9)52.8 (35.4-69.6)40.6 (27.6-55.2)
>3 doses19.5 (17.8-21.4)14.9 (9.7-22.3)14.7 (11.4-18.8)NANA

 
* Estimate presented as point estimate (%) ± 95% confidence interval (CI). Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6.
† Estimate may be unreliable; (CI width)>20.
§ Adolescents in the 2008 NIS-Teen were born during January 1990 - February 1996. Vaccination coverage estimates include only adolescents who had adequately complete provider-reported immunization records.
¶ Reported by respondent. Adolescents of Hispanic ethnicity may be of any race. Native Hawaiian or other Pacific Islanders and persons of multiple races were not included because of small sample sizes
** Includes > 2 doses of measles-mumps-rubella vaccine.
††Includes >3 doses of hepatitis B vaccine.
§§By parent/guardian report or provider records.
¶¶ Includes > 1 dose of tetanus toxoid-diphtheria vaccine (Td) or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years.
*** Includes percentages receiving meningococcal conjugate vaccine (MCV4) and meningococcal -unknown type vaccine.
††† Quadrivalent human papillomavirus vaccine. Percentages reported among females only (n=8,607); since HPV4 vaccine is only recommended for females.
tab15_race_nat